r , Quantification of NMDA-induced (50 M) intracellular calcium rises (%F/F 0 ) following bath application of GLP-1 (1 M, n = 20 neurons) or GLP-1MK-801 (1 M, n = 38 neurons)
Decrease dose consideration: Persistent side effects including headaches, fatigue, or injection site reactions, excessive response (extremely rapid weight loss suggesting dose may be higher than needed), cost concerns when lower doses might achieve similar results
TEXT ON-SCREEN: If no drop appears, repeat flow check up to 6 times
Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
FengKHuangfuLLiuCBonfiliLXiangQWuHet al
